|
|
Volumn 12, Issue , 2012, Pages 398-
|
|
Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ADULT;
AGED;
ARTICLE;
AUSTRALIA;
CARDIOVASCULAR DISEASE;
COST BENEFIT ANALYSIS;
ECONOMICS;
FEMALE;
HEALTH CARE COST;
HUMAN;
MALE;
MIDDLE AGED;
PRACTICE GUIDELINE;
PREVENTIVE HEALTH SERVICE;
RISK FACTOR;
STANDARD;
STATISTICAL MODEL;
STATISTICS;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
AUSTRALIA;
CALCIUM CHANNEL BLOCKERS;
CARDIOVASCULAR DISEASES;
COST-BENEFIT ANALYSIS;
DIURETICS;
FEMALE;
HEALTH EXPENDITURES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MIDDLE AGED;
MODELS, ECONOMIC;
PRACTICE GUIDELINES AS TOPIC;
PREVENTIVE HEALTH SERVICES;
RISK FACTORS;
MLCS;
MLOWN;
|
|
EID: 84861688870
PISSN: None
EISSN: 14712458
Source Type: None
DOI: 10.1186/1471-2458-12-398 Document Type: Article |
|
Times cited : (56)
|
|
References (0)
|
